Investment Summary

Trilantic North America Invests In Sofie Biosciences

On June 4, 2024, private equity firm Trilantic North America invested in life science company Sofie Biosciences

Investment Highlights
  • This is Trilantic North America’s 1st transaction in the Life Science sector.
  • This is Trilantic North America’s 49th transaction in the United States.
  • This is Trilantic North America’s 1st transaction in Virginia.

Investment Summary

Date 2024-06-04
Target Sofie Biosciences
Sector Life Science
Investor(s) Trilantic North America
Deal Type Growth Capital
Advisor(s) Solomon Partners (Financial)
Paul, Weiss, Rifkind, Wharton & Garrison (Legal)

Target

Sofie Biosciences

Dulles, Virginia, United States
Sofie Biosciences is a molecular imaging company combining new PET imaging diagnostics with innovative imaging and synthesis systems to provide researchers and physicians with tools to better investigate the biology of disease. Sofie Biosciences is based in Dulles, Virginia.

Search 197,704 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Trilantic North America

New York, New York, United States

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 2009
PE ASSETS 9.6B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Trilantic North America is a mega-sized private equity firm focused on opportunities throughout North America. Trilantic generally invests in large businesses with 'strong market positions, unique franchises, secure and growing market niches or distinctive products and services that command premium prices'. Sectors of interest include business services, consumer, energy, and financial services. The Firm's target investment size is $50 to $300 million in companies valued up to $1 billion. Transaction situations of interest include management buyouts, recapitalizations, growth capital financings, divestitures, new platforms, and generational transfers. Trilantic North America was formed in 2009 through the spin-off of Lehman Brothers' private equity business. The Firm is based in New York City.


DEAL STATS #
Overall 51 of 51
Sector (Life Science) 1 of 1
Type (Growth Capital) 16 of 16
State (Virginia) 1 of 1
Country (United States) 49 of 49
Year (2024) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-08-03 TSC Miami

Miami Gardens, Florida, United States

TSC Miami is a tech-enabled digital and screen printing and fulfillment platform for apparel and accessories selling into ecommerce, retail and creator end markets. TSC Miami was founded in 2001 and is based in Miami Gardens, Florida.

Buy -